Claude Emond

• Adipose Tissue Pollutants And Obesity
  

Dr. Claude Emond is a Clinical Assistant Professor in the Department of Environmental and Occupational Health at the University of Montreal, Canada, and Associate Professor at the Institute of Environmental Sciences (ISE) at the University of Quebec in Montreal (UQAM). In this capacity, Dr. Emond delivers lectures in Toxicology classes at the university and supervises graduate students. He received a bachelor’s degree in Biochemistry from the University of Montreal in Quebec in 1987, a master’s degree in Environmental Health from the University of Montreal in 1997, and a Ph.D. in Public Health (Toxicology and Human Risk Assessment option) in 2001 from the University of Montreal. From 2001 to 2004, Dr. Emond received grants from the National Research Council, a branch of the National Academy of Sciences (NAS), to perform postdoctoral studies for 2½ years at the U.S. Environmental Protection Agency (EPA) in North Carolina. At EPA, Dr. Emond’s work focused on describing a developmental physiologically based pharmacokinetic (PBPK) model on dioxins. His research and consulting interests address problems in toxicology and focus on different chemicals, including polychlorinated biphenyls (PCBs), dioxins, flame retardants (polybrominated diphenyl ether [PBDE] and hexabromocyclododecane [HBCD]), bisphenol A, pyrethroid, and xenoestrogens. Dr. Emond’s research interests also focus on the development and the improvement of mathematical PBPK models to address and reduce the uncertainty for toxicology risk assessment in human health. Much of his research activities focus on the toxicokinetic and dynamic effects to further characterize the mode of action between chemicals and biological matrices for individuals or populations. He is also interested in occupational toxicology, mainly on the effects of organic solvents, modeling physiological changes in aging compared to younger workers, and nanotoxicology. Dr. Emond recently served on EPA’s Science Advisory Board Reviewing Committee for Trichloroethylene (TCE). His expertise was recognized and used in the dioxin reassessment by EPA’s National Center for Environmental Assessment. In 2008, Dr. Emond and colleagues founded an international nanotoxicology group called The International Team in Nanotoxicology (www.TITNT.com), which includes collaborators from five different countries. He also recently founded a Delaware-based consulting company called BioSimulation Consulting Inc., which provides services in pharmacokinetics for government by offering analytical data-mining support. He is President of an Endocrine Disruptor Review Work Group for the French Agency for Food, Environmental, and Occupational Health and Safety (ANSES). HeDr. Emond has published many papers and is often invited to present his research at international meetings on persistent organic chemicals and nanotechnology because his work contributes to the improvement of health, safety, and environmental assessment and regulations.